Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1979 1
1980 3
1981 1
1984 2
1985 2
1986 1
1987 1
1988 1
1989 3
1990 1
1991 1
1992 2
1993 2
1994 4
1995 1
1997 1
1998 1
1999 1
2000 2
2001 4
2002 9
2003 12
2004 23
2005 33
2006 31
2007 16
2008 28
2009 22
2010 26
2011 38
2012 42
2013 40
2014 31
2015 37
2016 24
2017 37
2018 42
2019 35
2020 60
2021 81
2022 82
2023 51
2024 53
2025 34

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

800 results

Results by year

Filters applied: . Clear all
Page 1
Non-Surgical Management of Urinary Incontinence.
Al-Dossari R, Kalra M, Adkison J, Nguyen BM. Al-Dossari R, et al. Among authors: kalra m. J Am Board Fam Med. 2024 Sep-Oct;37(5):909-918. doi: 10.3122/jabfm.2023.230471R1. J Am Board Fam Med. 2024. PMID: 39978852 Free article. Review.
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study.
Li BT, Meric-Bernstam F, Bardia A, Naito Y, Siena S, Aftimos P, Anderson I, Curigliano G, de Miguel M, Kalra M, Oh DY, Park JO, Postel-Vinay S, Rha SY, Satoh T, Spanggaard I, Michelini F, Smith A, Machado KK, Saura C; DESTINY-PanTumor01 study group. Li BT, et al. Among authors: kalra m. Lancet Oncol. 2024 Jun;25(6):707-719. doi: 10.1016/S1470-2045(24)00140-2. Epub 2024 May 3. Lancet Oncol. 2024. PMID: 38710187 Clinical Trial.
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.
Hegde M, Navai S, DeRenzo C, Joseph SK, Sanber K, Wu M, Gad AZ, Janeway KA, Campbell M, Mullikin D, Nawas Z, Robertson C, Mathew PR, Zhang H, Mehta B, Bhat RR, Major A, Shree A, Gerken C, Kalra M, Chakraborty R, Thakkar SG, Dakhova O, Salsman VS, Grilley B, Lapteva N, Gee A, Dotti G, Bao R, Salem AH, Wang T, Brenner MK, Heslop HE, Wels WS, Hicks MJ, Gottschalk S, Ahmed N. Hegde M, et al. Among authors: kalra m. Nat Cancer. 2024 Jun;5(6):880-894. doi: 10.1038/s43018-024-00749-6. Epub 2024 Apr 24. Nat Cancer. 2024. PMID: 38658775 Free PMC article. Clinical Trial.
Difficulty Swallowing.
Kalra M, Pemberton E. Kalra M, et al. Am Fam Physician. 2025 Aug;112(2):205-206. Am Fam Physician. 2025. PMID: 40834379 No abstract available.
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S. Ahmed N, et al. Among authors: kalra m. JAMA Oncol. 2017 Aug 1;3(8):1094-1101. doi: 10.1001/jamaoncol.2017.0184. JAMA Oncol. 2017. PMID: 28426845 Free PMC article. Clinical Trial.
Justification: gain or game.
Kalra MK, Bernardo MO, Karout L, Dos Santos AASMD. Kalra MK, et al. Radiol Bras. 2024 May 7;57:e20230117. doi: 10.1590/0100-3984.2023.0117. eCollection 2024 Jan-Dec. Radiol Bras. 2024. PMID: 38993958 Free PMC article. No abstract available.
AI-based diagnosis of acute aortic syndrome from noncontrast CT.
Hu Y, Xiang Y, Zhou YJ, He Y, Lang D, Yang S, Du X, Den C, Xu Y, Wang G, Ding Z, Huang J, Zhao W, Wu X, Li D, Zhu Q, Li Z, Qiu C, Wu Z, He Y, Tian C, Qiu Y, Lin Z, Zhang X, Hu L, He Y, Yuan Z, Zhou X, Fan R, Chen R, Guo W, Xu J, Zhang J, Mok TCW, Li Z, Kalra MK, Lu L, Xiao W, Li X, Bian Y, Shao C, Wang G, Lu W, Huang Z, Xu M, Zhang H. Hu Y, et al. Among authors: kalra mk. Nat Med. 2025 Nov;31(11):3832-3844. doi: 10.1038/s41591-025-03916-z. Epub 2025 Aug 20. Nat Med. 2025. PMID: 40835970 Free PMC article.
Authors' reply.
Lyhne MD, Giordano N, Dudzinski D, Torrey J, Wang G, Zheng H, Parry BA, Kalra MK, Kabrhel C. Lyhne MD, et al. Among authors: kalra mk. Emerg Radiol. 2023 Aug;30(4):565-566. doi: 10.1007/s10140-023-02145-6. Epub 2023 Jun 10. Emerg Radiol. 2023. PMID: 37301788 No abstract available.
Dose optimization in cardiac CT.
Hedgire S, Ghoshhajra B, Kalra M. Hedgire S, et al. Among authors: kalra m. Phys Med. 2017 Sep;41:97-103. doi: 10.1016/j.ejmp.2017.04.021. Epub 2017 May 12. Phys Med. 2017. PMID: 28506649 Review.
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.
Wermke M, Araujo DM, Chatterjee M, Tsimberidou AM, Holderried TAW, Jazaeri AA, Reshef R, Bokemeyer C, Alsdorf W, Wetzko K, Brossart P, Aslan K, Backert L, Bunk S, Fritsche J, Gulde S, Hengler S, Hilf N, Hossain MB, Hukelmann J, Kalra M, Krishna D, Kursunel MA, Maurer D, Mayer-Mokler A, Mendrzyk R, Mohamed A, Pozo K, Satelli A, Letizia M, Schuster H, Schoor O, Wagner C, Rammensee HG, Reinhardt C, Singh-Jasuja H, Walter S, Weinschenk T, Luke JJ, Britten CM. Wermke M, et al. Among authors: kalra m. Nat Med. 2025 Jul;31(7):2365-2374. doi: 10.1038/s41591-025-03650-6. Epub 2025 Apr 9. Nat Med. 2025. PMID: 40205198 Free PMC article. Clinical Trial.
800 results